Johnson John

Insider·Xeris Biopharma Holdings, Inc.·XERS·Insider since 2025·Form 4 filings: 7
Trades YTD
0
Trades (12m)
7
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

7 transactions
19 Dec 2025
SOLD
$XERS
135,400
$7.22
S
09 Dec 2025
SOLD
$AXGN
13,141
$29.98
S
09 Dec 2025
SOLD
$AXGN
8,545
$29.98
S
08 Dec 2025
SOLD
$AXGN
11,891
$31.22
S
08 Dec 2025
SOLD
$AXGN
11,802
$31.26
S
13 Aug 2025
SOLD
$XERS
107,500
$7.32
S
09 Jun 2025
SOLD
$AXGN
4,073
$10.61
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Xeris Biopharma Holdings, Inc.

last 30 days

No active insider cluster at Xeris Biopharma Holdings, Inc. in the last 30 days. John's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event John is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 13:51 UTC.